Sunday, February 3, 2008

FDA Warns Pfizer

The Federal Drug Administration has issued a warning to pharmaceutical giant, Pfizer, over their anti-smoking drug, Chantix.

Pfizer has already added a warning to the drug, telling consumers it may lead to suicidal thoughts. However, the FDA said they have reviewed several cases which suggest exposure to the drug may have been the mitigating factor in their suicidal thoughts and actions.

Apparently, the council has received over 500 cases of suicidal thoughts and attempts; just under 50 resulted in death.

While Pfizer has a "warning" on their Chantix website, it is worded so as to suggest that patients who experience these problems already have, or once had, psychiatric issues. Further, it never once mentions suicide specifically.

Chantix was approved by the FDA in 2006.
Chantix had sales nearing $300 million in 2007.

© C Harris Lynn, 2008

No comments:

Post a Comment